Parechovirus

Anna Sick-Samuels, M.D., M.P.H.
Parechovirus is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

MICROBIOLOGY

  • Parechovirus (PeV) is a non-enveloped single-stranded RNA virus from the viral family Picornaviridae. Other members of this family include Enteroviruses (Echoviruses, Coxsackie viruses, and Poliovirus) and Rhinoviruses.
  • Four species of PeV A through D. PeV-A is a recognized human pathogen with 19 genotypes.
    • PeV-A1 (previously called echovirus 22) is commonly associated with gastrointestinal and respiratory illnesses and commonly circulates in the community.
    • PeV-A3 has a tropism for neuronal cells and is more often associated with neonatal sepsis and encephalitis. Because PeV-A3 is a less common strain, mothers may not have pre-existing protective antibodies, increasing the risk of neonatal infection.

-- To view the remaining sections of this topic, please or --

MICROBIOLOGY

  • Parechovirus (PeV) is a non-enveloped single-stranded RNA virus from the viral family Picornaviridae. Other members of this family include Enteroviruses (Echoviruses, Coxsackie viruses, and Poliovirus) and Rhinoviruses.
  • Four species of PeV A through D. PeV-A is a recognized human pathogen with 19 genotypes.
    • PeV-A1 (previously called echovirus 22) is commonly associated with gastrointestinal and respiratory illnesses and commonly circulates in the community.
    • PeV-A3 has a tropism for neuronal cells and is more often associated with neonatal sepsis and encephalitis. Because PeV-A3 is a less common strain, mothers may not have pre-existing protective antibodies, increasing the risk of neonatal infection.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 18, 2022